BIOLASE Announces Agreement With DSO Dental Care AllianceBIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States
BIOL announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations (DSO) in the United States with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs in targeted geographies. The Company expects the agreement to lead to a rollout across all DCA offices in 2021.
finance.yahoo.com
Stockmarkets
USWS and RRC Finalize Extension of Electric Frac Contract U.S. Well Services and Range Resources Corp. Finalize Extension of Electric Frac Contract
finalized an extension of its contract to provide electric hydraulic fracturing services-revolutionary Clean Fleet® electric hydraulic fracturing solution for Range Resources Corp. (NYSE: RRC) in the Appalachian Basin.
finance.yahoo.com stock
How To Start A Successful Trading BusinessWhen you start trading, you need to go into it like you would if you were getting ready to start a business.
Too often, I see new ‘traders’ who open their account and before ever mapping out any goals, a strategy, a trading plan, or anything, they’re already putting money into the markets…
…and for me, this isn’t trading, this is gambling.
So in this article, I’m going to walk you through how you can start your own successful trading business.
So let’s dive in!
Starting A Trading Business: Step 1 – Charting Software
First, as a technical trader (like me) you MUST have good charting software.
Charting software is your window into the world of stocks.
As a technical trader, we rely on charts and indicators to find high-probability setups.
Charting software with good indicators is an essential first step in your path to being a successful trader.
I personally use (and highly recommend) TradingView.
It is a paid service and for what I do, I use the Pro Version which currently costs $14.95 per month but it is well worth it.
Remember, starting your own successful trading business requires a modest investment into the ‘infrastructure’ of your business.
Step 2 – Finding The Right Broker
Now on to step 2, finding the right broker for you!
Finding the right broker can be a tricky process, especially if you live outside of the United States.
If you’re trading stocks and options, I highly recommend tastyworks, or Interactive Brokers if you live outside the U.S.
Starting A Trading Business: Step 3 – Trading Strategy
Next, now that you have your charting software and broker, every trader needs a good trading strategy.
Similar to the broker, one size does not fit all. Why?
Well, there are a LOT of variables that can go into developing your trading strategy.
For example, are you trading for Income or Growth or the amount you have to trade with?
All of these things play a big factor in the type of strategy you want to, can, or should trade. Right now, I’m trading two strategies. My core strategies right now are, The PowerX Strategy and The Wheel.
Step 4 – Trading Computer
The next thing to consider when getting your trading business set up is you will need a computer.
Almost all brokers and trading software are cloud-based, so you don’t need a seriously advanced computer anymore.
Most computers that are less than 3 years old should be more than powerful enough to run even the most system-intensive trading platform.
Step 5 – Additional Monitors.
Now, for your home set up, I think at least one additional monitor is a must. The good news is that if you have a laptop, you already have one monitor! If you travel a lot (like me) I would highly recommend the ASUS MB169B+ 15.6″ Full HD 1920×1080 IPS USB Portable Monitor.
They’re lightweight and work great on the road or at home. It fits easily in my backpack (because I HATE checking bags) and doesn’t add much weight.
Step 6 – Trading Newsletters
Next, over my morning coffee, I like to read a few different trading newsletters.
I have three primary newsletters right now where I get most of my market-related news.
Most of the talking heads on TV are absolutely terrible for getting non-biased information anymore.
No matter what station, everything you hear is coming through some sort of filter.
For this reason, I stick with these three newsletters that I’ve found to provide good info:
- Morning Brew
- Seeking Alpha’s Wall Street Breakfast
- The Rockwell Trading Newsletter
Summary
Now that you have all of the pieces in place to start your trading business off on the right foot, in my next article I’m going to go through something that at first, I’m sure you will cringe: Trading Taxes.
But I assure you if you’re proactive and take the time to get set up and structured properly, taxes aren’t actually as bad as you’d think for full-time traders.
I hope this has helped and you’ve enjoyed it.
Good trading!
Reduction in Heart Attacks, Strokes and Cardiac DeathSingle Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure
results from the landmark DREAM-HF randomized controlled Phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who received rexlemestrocel-L (REVASCOR®) or control sham.
A single dose of rexlemestrocel-L resulted in substantial and durable reductions in heart attacks, strokes, and cardiac deaths.
The incidence of heart attacks and strokes were reduced by 60% over a median follow-up period of 30 months following a single dose of rexlemestrocel-L in the population of 537 patients with New York Heart Association (NYHA) class II or III chronic heart failure (5% vs 13%, p=0.002).
The incidence of death from cardiovascular causes was reduced by 60% following a single dose of rexlemestrocel-L in the 206 patients with NYHA class II disease (8% vs 20%, p=0.037)
finance.yahoo.com
LM Funding Announces Filing of SPAC Registration StatementLM Funding Announces Filing of SPAC Registration Statement
LMFA today announced that LMF Acquisition Opportunities, Inc., a special purpose acquisition company and an indirect subsidiary of the Company ("LMF Acquisition"), filed a Registration Statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission ("SEC") in connection with a proposed initial public offering of its units. LMF Acquisition intends to search for a target in the financial services industry, including potentially the financial technology (FinTech) sector, and related sectors.
The proposed public offering is expected to have a base offering size of $75 million, or up to $86.25 million if the underwriters' over-allotment option is exercised in full.
finance.yahoo.com
Why Qudian Stock Popped higher in 2021?Why Qudian Stock Popped higher in 2021?
On Dec 30, 2020 in Brussels, European Union negotiators finalized the terms of a historic investment agreement with China. Seven years in the making, the new Comprehensive Agreement on Investment is expected to grow international trade between the EU and China, facilitate cross-border investment, and "strongly stimulate" the economies of both nations, according to Chinese president Xi Jinping.
CNN highlighted the financial services sector, electric vehicles, and healthcare as three areas of the Chinese economy likely to benefit especially from the trade accord.
Don't expect to see immediate benefits for Qudian Stock, however. Just because negotiators have signed the deal doesn't mean that their respective legislatures will ratify it, and the Comprehensive Agreement can't go into effect before that happens.
According to FT, EU officials are targeting an effective date for the agreement no earlier than 2022.
www.fool.com
ALDX Announces Positive Top-Line Symptom and Sign ResultsAldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease
Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign, and Clinical Symptoms of Ocular Dryness and Discomfort
Acute Improvement in Ocular Redness and Symptom Scores Demonstrated Within Minutes of Reproxalap Administration in Dry Eye Chamber
Main Cohort of TRANQUILITY Expected to Begin Enrollment in February 2021, Following Completion of Tear RASP Analysis and Finalization of Trial Design
finance.yahoo.com
Why CNET 3D-Printing Stock Soared YesterdayShares of 3D-printing companies rose sharply on Thursday after 3D Systems (NYSE:DDD) reported blockbuster preliminary results for the fourth quarter.
This news has given investors hope that other companies in the sector will report similarly strong results.
in the first three quarters of 2020, Stratasys's total revenue fell by more than 20% year over year.
The strong preliminary results from 3D Systems are sparking investor optimism that the 3D-printing industry is about to come roaring back as manufacturing activity picks up and economies start to recover from the havoc caused by the pandemic.
www.fool.com
Completes Sale of Cimatron and GibbsCAM Businesses3D Systems Completes Sale of Cimatron and GibbsCAM Businesses and Provides Preliminary Financial Results for Fourth Quarter 2020
- Announces Date of Fourth Quarter and Full Year 2020 Financial Results
- Close of sale of non-core software businesses for cash proceeds of approximately $64 million
- Repayment of all debt outstanding under senior secured term loan. With the paydown of the term loan, the company is now free of any outstanding debt but continues to have availability under its senior secured revolving credit facility, which remains fully undrawn at this point.
- Official termination of ‘At-the-Market’ Equity Offering Program
- Strong Q4 preliminary financial performance with expected revenues between $170 million and $176 million
- Expected revenue reflects strong organic growth exceeding 20% in both Healthcare and Industrial business units on a consecutive quarter basis.
Essentially debt-free now, and free to focus on its two core 3D printer making businesses (industrial and healthcare), the company also noted that in addition to the better-than-expected sales, it is likely to report anywhere from $11 million to $19 million in pro forma profit for Q4.
Generally accepted accounting principles (GAAP) results could still be as bad as an $8.6 million loss, but there's at least the possibility that 3D will eke out a GAAP profit of as much as $0.5 million this quarter.
finance.yahoo.com
“Strong Buy” Penny Stock That Could Deliver Massive Returns“Strong Buy” Penny Stock That Could Deliver Massive Returns
The company’s development pipeline features drug candidates under investigation as treatments for short bowel syndrome (SBS) and celiac disease (CeD), two conditions that are both dangerous and difficult to treat.
9 Meters’ flagship product, Larazotide, is in Phase 3 development for the treatment of CeD. CeD affects about 1% of the population, yet there are no approved therapies. Top-line data from the study is expected in the second half of 2021.
this past December, the company announced that it had entered an agreement with EBRIS, the European Biomedical Research Institute of Salerno, to investigate Larazotide as a potential treatment for respiratory complications due to COVID-19.
The other major drug in the company’s pipeline is NM-002, for SBS. The company has recently announced positive Phase 1b/2a results, with a measurable impact on disease symptoms from a compound that was well-tolerated by patients.
finance.yahoo.com
"Blue Wave" A Black Swan Event? Stock Market Drop!Wild day on Wall Street. The S&P 500, the Nasdaq, the Dow Jones all did finish lower, but WELL off the lows. Last week, I mentioned how this week would be big with the Georgia (GA) Senate run off and then the December 6th Electoral College vote. The GA Senate run is the big one.
If the Democrat Candidates win both seats tomorrow, the Senate is split 50-50 between the Democrats and the Republicans, but the Vice President gets the determining vote, and since that person is a Democrat, the Democrats technically take the Senate.
This means that they can pass the programs that they want. The current set up, with a Democratic President and a Republicans controlled Senate is the Goldilocks zone. Balance and checks remain so the Democrats cannot pass large programs.
"Strikingly, while online betting markets priced in a relatively modest 25-30% probability of a blue sweep (i.e., Democrats winning both GA runoffs tomorrow), the Predictit odds for a "blue wave" have soared in the past few days, surging just shy of 50%." In fact, we went slightly above 50% today.
To me, this would meet the definition of a Black Swan Event. Something the market is NOT pricing in. So there is a possibility we drift lower given the outcome tomorrow (perhaps market pricing this in NOW). Just want to be clear: this is not telling us the Dems win the Senate tomorrow, it is just a possibility that the markets are fearing and reacting to.
If the Republicans maintain the Senate, markets will continue their uptrend as we remain in the Goldilocks zone.
If we get the Dem outcome, we can continue a move lower.
The zones I would look at would be on the Daily chart. For the S&P, there is a possibility we are forming a head and shoulders reversal pattern. The 3640 is a major support zone that I am watching if price drops lower. One can make a case there is a flip zone at 3700, and the daily close is indeed closing back above.
If we do hit 3640, expect a bounce and then our right shoulder eventually breaking below 3640. That would be my short trigger. I would target 3530, and then 3400 below that.
BUT you all know my outlook on the monetary and fiscal side. Cheap and easy money is here to stay. It cannot stop and it will not stop. So yes, there is a chance the S&P 500 and other US Stock Markets drop on the "Blue Wave", but I do think the dip eventually gets bid up.
The Federal Reserve is not stopping its asset purchasing program anytime soon. Interest Rates will be suppressed, and stock markets will continue to be the only place to go for yield.
A Blue Wave means even MORE money will be spent. Democrats are generally big spenders. Stock markets continue to be the only place to go for real yield. You all know my thoughts on Gold, Silver and Cryptocurrency. This is where you want to be to preserve purchasing power!
Expect a highly volatile week. At the end of the week, I would not be surprised to see the tone change. What started as a red week on wall street, turns to be a positive week for wall street. I welcome this relief rally, and further pressure if it plays out. Profits must be taken and the markets need to give back some!
Watching quotients can give a good edge about the market This time is AMEX:SPY / AMEX:UST which compares the U.S. stock market with the U.S. bond market. So, right now is heading to test a very strong resistance in 5.20 points, while for the last few weeks is been divergent from its RSI, all "selling signals". Normally when this quotient gives this signals is because the stock market is losing strength and a correction is on the way because the "smart money" is selling stocks to buy bonds.
There's no way to predict how strong could be the correction or even if it will happen, the best thing you could do is to rise stop-loss, sell extended stocks and low stock positions. That is what I have been doing.
LOAC Announces Signing of Definitive Merger AgreementLongevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
4D pharma's Live Biotherapeutic Products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has six clinical programs
At the effective time of the merger, each of LOAC's ordinary shares issued and outstanding prior to the effective time of the merger will be automatically converted into the right to receive certain per share merger consideration, and each warrant to purchase LOAC's ordinary shares and right to receive LOAC's ordinary shares that is outstanding immediately prior to the effective time of the merger will be assumed by 4D pharma and automatically converted into a warrant to purchase ordinary shares of 4D pharma and a right to receive ordinary shares of 4D pharma, payable in 4D pharma ADSs, respectively.
www.prnewswire.com
Cano Health to Become Publicly Traded via Merger with JWSCano Health, a Leading Value-Based Care Delivery Platform for Seniors, to Become Publicly Traded via Merger with Jaws Acquisition Corp.
- Transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million
- PIPE led by $50 million investment from Barry Sternlicht, Chairman of Jaws, as well as commitments from funds affiliated with Fidelity Management & Research Company, funds and accounts managed by BlackRock, Third Point and Maverick Capital
Cano Health provides value-based care for more than 103,000 members through its network of 564 primary care physicians across 14 markets in Florida, Texas, Nevada and Puerto Rico.
The Company is expected to receive up to $935 million in transaction proceeds to pay down debt and provide growth capital, and a substantial majority of up to $465 million of proceeds is expected to be allocated to Cano Health's financial sponsor.
The transaction is expected to close at the end of the first quarter or the beginning of the second quarter of 2021.
finance.yahoo.com
Air T, Inc. Announces Intent to Form New Aircraft Equity VehicleAir T, Inc. Announces Intent to Form New Aircraft Equity Vehicle
AIRT) announced today that it has entered into letters of intent with three separate, large investment and asset management firms (the "Investors") to form a new aircraft asset management business to be called Contrail Aircraft Management ("CAM"), and a new aircraft capital joint venture to be called Contrail Fund II ("CFII").
The parties presently expect the new business and joint venture to be formed and capitalized by the end of January 2021.
The new business and joint venture are being formed to purchase and sell aircraft and engines to be relet or disassembled and sold for parts. The parties anticipate that CFII will be capitalized initially with approximately $108,000,000 in equity capital and that it will establish a portfolio of aircraft assets, focusing on whole aircraft and engine acquisitions, sale-leaseback transactions and end of life part-out solutions. The capital contributed by the Investors -- presently anticipated to be approximately $100,000,000 -- will be contributed into CFII.
The Upsize Commitment is anticipated to exceed $250,000,000. Contrail intends to contribute approximately $8,000,000 of the initial capital committed to the fund as well, which is anticipated to lead to returns alongside the other investors.
finance.yahoo.com
Eos Energy Secures Contract valued at $2 millionEos Energy Secures Contract to provide Safe, Sustainable Storage to California Hospital
Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), today announced it has a firm order from Charge Bliss, Inc. (“CBI”), a renewable energy microgrid developer/builder, to provide a critical care hospital with 2 MW of energy storage using its Znyth® battery. The deal is valued at $2 million.
“We are proud to collaborate with Charge Bliss to provide safe and reliable storage for a hospital micro grid application,”
Eos will provide this groundbreaking project with up to 2 MW of continuous power delivery upon installation, which is scheduled to take place in the second quarter of 2021.
“Our microgrid systems are engineered to supply clean energy while reducing peak demand,”
finance.yahoo.com
Expected net revenue increasedFourth quarter 2020 net revenue is expected to be approximately $3.5 million, increased from the prior expectation of approximately $2.5 million
Received communication from the FDA explaining the reallocation of agency resources to address Emergency Use Authorization (EUA) applications for products related to the COVID-19 public health emergency is affecting marketing application reviews, including the Eversense 180-day product, which will be delayed by at least 60 days. This is consistent with what Senseonics understands other medical technology companies have reported.
Inclusion of Eversense Category III CPT codes in the Centers for Medicare & Medicaid Services (CMS) 2021 Physician Fee Schedule (PFS), establishing global payment for the device cost and procedure fees for healthcare providers across the United States
Full year 2021 net revenue is expected to be between $12 and $15 million, based on installed base, acceleration of Ascensia’s commercial activities and other factors
Reached agreement with Roche to facilitate transition of distribution to Ascensia, as Roche sales conclude January 31, 2021, including final purchases, transition support activities, and resolution of other matters
Highbridge second lien loan extinguished through completed conversion of their second lien debt to common stock, simplifying capital structure
"Strong fourth quarter performance was driven by sales in Europe and supported by Ascensia’s initial US sales."
We remain confident that the PROMISE study demonstrates that the excellent performance of the current Eversense system is extended for up to 180 days, and that there still is potential for a decision from the agency by the end of the end of the second quarter
finance.yahoo.com
ION Acquisition Soars on Taboola SPAC Merger RumorsION Acquisition Soars on Taboola SPAC Merger Rumors
IACA stock’s October initial public offering raised $225 million for the special purpose acquisition company (SPAC) focusing on the Middle East region. Its stated goal was a merger with a private company valued at more than $1 billion. That IPO was upsized by more than 10% to 22.5 million units ahead of the floatation. Both ION and Taboola are based in Israel.
Daily Haaretz reported on Monday that Taboola was mulling either a SPAC merger or its own IPO. Its sister publication, business daily TheMarker, on Tuesday reported the ION-Taboola negotiations.
investorplace.com
Ouster to Combine With Colonnade Acquisition CorpOuster, a Leading Provider of High-Performance Digital Lidar Sensors, to Combine With Colonnade Acquisition Corp. to Accelerate Digital Lidar Adoption in Industrial, Smart Infrastructure, Robotics, and Automotive Markets.
Transaction expected to provide up to $300 million in gross proceeds, comprised of Colonnade Acquisition Corp.’s $200 million of cash held in trust (assuming no redemptions) and a $100 million fully committed common stock PIPE at $10.00 per share, including from Ouster’s existing investors, Cox Enterprises, Fontinalis Partners, and WWJr Enterprises.
Pro forma implied enterprise value of ~$1.6 billion and fully diluted pro forma equity value of ~$1.9 billion
Ouster shareholders will roll 100% of their equity holdings into the combined company
The boards of directors of both Ouster and Colonnade have unanimously approved the proposed business combination, which is expected to be completed in the first half of 2021, subject to, among other things, the approval by Colonnade's shareholders and Ouster’s shareholders, satisfaction of the minimum cash condition, which is equal to the $100 million committed common stock PIPE investment at $10.00 per share obtained in connection with the entry into the Merger Agreement, and certain other customary closing conditions stated in the Merger Agreement.
www.businesswire.com
Ameren Signs Long-Term 900 MHz Spectrum LeasesAmeren Signs Long-Term 900 MHz Spectrum Leases for Illinois & Missouri Service Territories
Anterix (NASDAQ: ATEX) today announced its first long-term 900 MHz broadband spectrum lease agreements, covering Ameren Corporation's ("Ameren") service territories for 30 years. These agreements enable Ameren's deployment of a private LTE network to support its digital transformation to deliver benefits for millions of Ameren customers in Illinois and Missouri.
finance.yahoo.com
Katapult to Become a Publicly Traded Company Through MergerKatapult to Become a Publicly Traded Company Through Merger With FinServ Acquisition Corp.
Leading e-commerce focused point-of-sale platform for nonprime consumers
Transaction values Katapult at a pro forma enterprise value of approximately $1 billion and equity value of $962 million, representing EV/EBITDA multiples of 14.1x and 6.6x projected EBITDA for 2021 and 2022, respectively. Total consideration paid to Katapult’s existing shareholders will be $833 million.
Cash proceeds of the transaction will fund up to $325 million of cash consideration to Katapult’s existing shareholders and $50 million of cash to Katapult’s balance sheet. The cash components of the transaction will be funded by FinServ’s cash in trust of $250 million
Transaction includes a $150 million fully committed PIPE at $10 per share from investors led by Tiger Global Management & Neuberger Berman Funds
Attractive, profitable financial profile with approximately $250 million of projected revenue (+172% y/y) for 2020
Proven and experienced management team, who will continue leading the combined company
The transaction is expected to close during the first half of 2021
www.businesswire.com
CURO Positioned to Benefit from Katapult’s Merger with FSRVCURO Group Holdings Corp. Positioned to Benefit from Katapult’s Announced Merger with FinServ Acquisition Corp.
$900+ million Transaction Provides $365 million Total Consideration to CURO
Katapult Holding, Inc. ("Katapult"), a company approximately 40% owned by CURO and a leading provider of e-commerce point-of-sale ("POS") lease purchase options for non-prime US consumers, and FinServ Acquisition Corp. (Nasdaq: FSRV) ("FinServ"), a publicly traded special purpose acquisition company ("SPAC"), have entered into a definitive merger agreement.
The transaction values Katapult’s equity at $908 million, which includes an earnout of up to $75 million in the form of additional common shares in the new public company.
Based on CURO’s ownership in Katapult, the transaction announced today will provide consideration consisting of a combination of cash and stock in the new company to CURO of $365 million , which includes an earnout of up to $30 million in the form of additional common shares in the new public company.
To date, CURO has made a total cash investment in Katapult of $27.5 million.
Upon the closing of the transaction, CURO anticipates receiving cash of up to $125 million and maintaining an ownership stake of at least 21% of the fully-diluted shares of the new public company.
The transaction is expected to close during the first half of 2021 and remains subject to approval by FinServ stockholders and other customary closing conditions.
finance.yahoo.com
DOW JONES -17/12/2020-• 2008 crisis comparison with 2020 pandemic
• Increased volatility during this year, even more than 2008 financial crisis
• Can be concluded just by looking at the candle sticks bodies
• V shape recovery priced in the markets, unlike officials reports
